Shares of EnteroMedics Inc. (NASDAQ: ETRM), a development-stage medical device company engaged in the design and development of devices that use neuroblocking technology to treat obesity, its associated co-morbidities, and other gastrointestinal disorders, are up sharply in trading today.
[...]
Recent Comments